These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 9782126)

  • 21. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.
    Ohashi PS; Oehen S; Aichele P; Pircher H; Odermatt B; Herrera P; Higuchi Y; Buerki K; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5185-94. PubMed ID: 8496610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent.
    Pechhold K; Patterson NB; Blum C; Fleischacker CL; Boehm BO; Harlan DM
    J Immunol; 2001 Feb; 166(4):2531-9. PubMed ID: 11160314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
    Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
    J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice.
    Laufer TM; von Herrath MG; Grusby MJ; Oldstone MB; Glimcher LH
    J Exp Med; 1993 Aug; 178(2):589-96. PubMed ID: 8101862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perforin-independent regulation of dendritic cell homeostasis by CD8(+) T cells in vivo: implications for adaptive immunotherapy.
    Ludewig B; Bonilla WV; Dumrese T; Odermatt B; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2001 Jun; 31(6):1772-9. PubMed ID: 11385622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells.
    Ludewig B; McCoy K; Pericin M; Ochsenbein AF; Dumrese T; Odermatt B; Toes RE; Melief CJ; Hengartner H; Zinkernagel RM
    J Immunol; 2001 Mar; 166(6):3678-87. PubMed ID: 11238607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes.
    Horwitz MS; Ilic A; Fine C; Rodriguez E; Sarvetnick N
    J Clin Invest; 2002 Jan; 109(1):79-87. PubMed ID: 11781353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired pMHC I complexes greatly enhance CD4(+) Th cell's stimulatory effect on CD8(+) T cell-mediated diabetes in transgenic RIP-mOVA mice.
    Ahmed KA; Xie Y; Zhang X; Xiang J
    Cell Mol Immunol; 2008 Dec; 5(6):407-15. PubMed ID: 19118506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model.
    Bresson D; von Herrath MG
    Clin Exp Immunol; 2011 Mar; 163(3):375-80. PubMed ID: 21235534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.
    Wong FS; Visintin I; Wen L; Granata J; Flavell R; Janeway CA
    J Exp Med; 1998 Jun; 187(12):1985-93. PubMed ID: 9625758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens.
    Hamilton-Williams EE; Lang A; Benke D; Davey GM; Wiesmüller KH; Kurts C
    J Immunol; 2005 Feb; 174(3):1159-63. PubMed ID: 15661868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.
    Lang KS; Recher M; Junt T; Navarini AA; Harris NL; Freigang S; Odermatt B; Conrad C; Ittner LM; Bauer S; Luther SA; Uematsu S; Akira S; Hengartner H; Zinkernagel RM
    Nat Med; 2005 Feb; 11(2):138-45. PubMed ID: 15654326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice.
    von Herrath MG; Dyrberg T; Oldstone MB
    J Clin Invest; 1996 Sep; 98(6):1324-31. PubMed ID: 8823297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.
    von Herrath MG; Dockter J; Oldstone MB
    Immunity; 1994 Jun; 1(3):231-42. PubMed ID: 7889411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance.
    von Herrath MG; Coon B; Wolfe T; Chatenoud L
    J Immunol; 2002 Jan; 168(2):933-41. PubMed ID: 11777992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA immunization to prevent autoimmune diabetes.
    Coon B; An LL; Whitton JL; von Herrath MG
    J Clin Invest; 1999 Jul; 104(2):189-94. PubMed ID: 10411548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
    J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice.
    Shinomiya M; Fazle Akbar SM; Shinomiya H; Onji M
    Clin Exp Immunol; 1999 Jul; 117(1):38-43. PubMed ID: 10403913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
    Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
    J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.